Highlights in autoimmune diseases from EBMT 2022

Highlights in autoimmune diseases from EBMT 2022

An overview of the aims & work of the ADWPПодробнее

An overview of the aims & work of the ADWP

EBMT TV 2022 – Episode 5Подробнее

EBMT TV 2022 – Episode 5

Cellular immunotherapy highlights from EBMT 2023Подробнее

Cellular immunotherapy highlights from EBMT 2023

EBMT TV Episode 4 | Wednesday, April 26Подробнее

EBMT TV Episode 4 | Wednesday, April 26

Highlights in autoimmune diseases from EBMT 2022Подробнее

Highlights in autoimmune diseases from EBMT 2022

EBMT TV 2022 – Episode 1Подробнее

EBMT TV 2022 – Episode 1

The role of CAR-T therapy and HSCT in autoimmune disordersПодробнее

The role of CAR-T therapy and HSCT in autoimmune disorders

Highlights from EBMT 2022Подробнее

Highlights from EBMT 2022

Highlights in quality management from EBMTПодробнее

Highlights in quality management from EBMT

Danny Altmann and Mark Peakman: Highlights in autoimmunity researchПодробнее

Danny Altmann and Mark Peakman: Highlights in autoimmunity research

5 Signs of Autoimmune Disease #rheumatoidarthritis #lupus #psoriaticarthritis #autoimmunediseaseПодробнее

5 Signs of Autoimmune Disease #rheumatoidarthritis #lupus #psoriaticarthritis #autoimmunedisease

Autoimmune Disease and Inflammation! ShortПодробнее

Autoimmune Disease and Inflammation! Short

Nursing highlights from the EBMT-EHA CAR T-cell MeetingПодробнее

Nursing highlights from the EBMT-EHA CAR T-cell Meeting

ADWP Educational Virtual Meeting September 2020 Welcome MessageПодробнее

ADWP Educational Virtual Meeting September 2020 Welcome Message

EBMT nurses’ program highlightsПодробнее

EBMT nurses’ program highlights

EBMT 2022: What are the highlights for the treatment of lymphoma?Подробнее

EBMT 2022: What are the highlights for the treatment of lymphoma?

A peek into the EBMT 2022 programПодробнее

A peek into the EBMT 2022 program

EBMT-EHA CAR T-cell highlights: new indications, new CAR-Ts & the microbiota’s impact on outcomesПодробнее

EBMT-EHA CAR T-cell highlights: new indications, new CAR-Ts & the microbiota’s impact on outcomes

Looking forward to EBMT 2022: get the latest updates in SCT and cellular therapiesПодробнее

Looking forward to EBMT 2022: get the latest updates in SCT and cellular therapies

Looking into the future of CAR-T therapy: cardiac fibrosis, infections & autoimmune diseasesПодробнее

Looking into the future of CAR-T therapy: cardiac fibrosis, infections & autoimmune diseases